Culturing conditions highly affect DNA methylation and gene expression levels in MCF7 breast cancer cell line

  • Lama Hamadneh
  • May Al-Majawleh
  • Yazun Jarrar
  • Sawsan Shraim
  • Mariam Hasan
  • Basha’er Abu-Irmaileh
Report
  • 36 Downloads

Abstract

The levels of DNA methylation and their role in gene expression are key factors that could affect diagnosis, prognosis, and treatment options of different diseases. In this study, the methylation levels of 22 genes that are mostly correlated to breast cancer were determined using EpiTect methyl II PCR array. This analysis was performed to determine the effect of cells’ passage number and the use of antibiotics in the culturing media on gene methylation levels in MCF7 cell line. DNA methylation levels of PTGS2, ADAM23, HIC1, and PYCARD were found to be significantly different among different passages. While the DNA methylation levels of CCNA1, RASSF1, and THBS1 were found to be affected by the use of 1% of penicillin/streptomycin in the culture media. Gene expression analysis after demethylation using 5-Aza-2′-deoxycytidine showed that the gene expression levels of the hypermethylated genes varied between different passage numbers. This study shows that the presence of antibiotic within cultured media and cell line’s passage number could greatly affect the methylation levels that need to be considered in future studies on cell lines.

Keywords

DNA methylation Breast cancer mcf-7 cell line Passage number Penicillin/streptomycin 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflicts of interest.

References

  1. Angulo JC, Andrés G, Ashour N, Sánchez-Chapado M, López JI, Ropero S (2016) Development of castration resistant prostate cancer can be predicted by a DNA hypermethylation profile. J Urol 195(3):619–626.  https://doi.org/10.1016/j.juro.2015.10.172 CrossRefPubMedGoogle Scholar
  2. Benevolenskaya EV, Islam AB, Ahsan H, Kibriya MG, Jasmine F, Wolff B, Al-Alem U, Wiley E, Kajdacsy-Balla A, Macias V, Rauscher GH (2016) DNA methylation and hormone receptor status in breast cancer. Clin Epigenetics 8:17.  https://doi.org/10.1186/s13148-016-0184-7 eCollection 2016CrossRefPubMedPubMedCentralGoogle Scholar
  3. Das PM, Singal R (2004) DNA methylation and cancer. J Clin Oncol 22(22):4632–4642CrossRefPubMedGoogle Scholar
  4. Foveau B, Boulay G, Pinte S, Van Rechem C, Rood BR, Leprince D (2012) The receptor tyrosine kinase EphA2 is a direct target gene of hypermethylated in cancer 1 (HIC1). J Biol Chem 287(8):5366–5378CrossRefPubMedGoogle Scholar
  5. Fridrichova I, Smolkova B, Kajabova V, Zmetakova I, Krivulcik T, Mego M, Cierna Z, Karaba M, Benca J, Pindak D, Bohac M, Repiska V, Danihel L (2015) CXCL12 and ADAM23 hypermethylation are associated with advanced breast cancers. Transl Res 165(6):717–730CrossRefPubMedGoogle Scholar
  6. Hayashi T, Hikichi M, Yukitake J, Harada N, Utsumi T (2017) Estradiol suppresses phosphorylation of ERα serine 167 through upregulation of PP2A in breast cancer cells. Oncol Lett 14(6):8060–8065.  https://doi.org/10.3892/ol.2017.7216 PubMedPubMedCentralGoogle Scholar
  7. Heitzer E, Artl M, Filipits M, Resel M, Graf R, Weißenbacher B, Lax S, Gnant M, Wrba F, Greil R, Dietze O, Hofbauer F, Böhm G, Höfler G, Samonigg H, Schaberl-Moser R, Balic M, Dandachi N (2014) Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1. Mod Pathol 27(6):906–915.  https://doi.org/10.1038/modpathol.2013.204 CrossRefPubMedGoogle Scholar
  8. Hinshelwood RA, Huschtscha LI, Melki J, Stirzaker C, Abdipranoto A, Vissel B, Ravasi T, Wells CA, Hume DA, Reddel RR, Clark SJ (2007) Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis. Cancer Res 67(24):11517–11527CrossRefPubMedGoogle Scholar
  9. Kinarivala N, Shah K, Abbruscato TJ, Trippier PC (2017) Passage variation of PC12 cells results in inconsistent susceptibility to externally induced apoptosis. ACS Chem Neurosci 8(1):82–88.  https://doi.org/10.1021/acschemneuro.6b00208 CrossRefPubMedGoogle Scholar
  10. Klajic J, Busato F, Edvardsen H, Touleimat N, Fleischer T, Bukholm I, Børresen-Dale AL, Lønning PE, Tost J, Kristensen VN (2014) DNA methylation status of key cell-cycle regulators such as CDKNA2/p16 and CCNA1 correlates with treatment response to doxorubicin and 5-fluorouracil in locally advanced breast tumors. Clin Cancer Res 20(24):6357–6366.  https://doi.org/10.1158/1078-0432.CCR-14-0297 CrossRefPubMedGoogle Scholar
  11. Kwist K, Bridges WC, Burg KJ (2016) The effect of cell passage number on osteogenic and castration characteristics of D1 cells. Cytotechnology 68(4):1661–1667.  https://doi.org/10.1007/s10616-015-9883-8 CrossRefPubMedGoogle Scholar
  12. Levine JJ, Stimson-Crider KM, Vertino PM (2003) Effects of methylation on expression of TMS1/ASC in human breast cancer cells. Oncogene 22(22):3475–3488CrossRefPubMedGoogle Scholar
  13. Mawlood SK, Dennany L, Watson N, Pickard BS (2016) The EpiTect Methyl qPCR Assay as novel age estimation method in forensic biology. Forensic Sci Int 264:132–138.  https://doi.org/10.1016/j.forsciint.2016.03.047 CrossRefPubMedGoogle Scholar
  14. Panahi Y, Beiraghdar F, Amirhamzeh A, Poursaleh Z, Saadat A, Sahebkar A (2015) Environmental toxicant exposure and cancer: the role of epigenetic changes and protection by phytochemicals. Curr Pharm Des 22(2):130–140CrossRefGoogle Scholar
  15. Papageorgis P, Lambert AW, Ozturk S, Gao F, Pan H, Manne U, Alekseyev YO, Thiagalingam A, Abdolmaleky HM, Lenburg M, Thiagalingam S (2010) Smad signaling is required to maintain epigenetic silencing during breast cancer progression. Cancer Res 70(3):968–978CrossRefPubMedPubMedCentralGoogle Scholar
  16. Roll JD, Rivenbark AG, Jones WD, Coleman WB (2008) DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines. Mol Cancer 7:15CrossRefPubMedPubMedCentralGoogle Scholar
  17. Shames DS, Girard L, Gao B, Sato M, Lewis CM, Shivapurkar N, Jiang A, Perou CM, Kim YH, Pollack JR, Fong KM, Lam CL, Wong M, Shyr Y, Nanda R, Olopade OI, Gerald W, Euhus DM, Shay JW, Gazdar AF, Minna JD (2006) A genome-wide screen for promoter methylation in lung cancer identifies novel methylationmarkers for multiple malignancies. PLoS Med 3(12):e486CrossRefPubMedPubMedCentralGoogle Scholar
  18. Tang Q, Cheng J, Cao X, Surowy H, Burwinkel B (2016) Blood-based DNA methylation as biomarker for breast cancer: a systematic review. Clin Epigenetics 8:115 eCollection 2016 67(24):11517–27CrossRefPubMedPubMedCentralGoogle Scholar
  19. Veeck J, Noetzel E, Bektas N, Jost E, Hartmann A, Knuchel R, Dahl E (2008) Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer. Mol Cancer 7:83CrossRefPubMedPubMedCentralGoogle Scholar
  20. Wagner E, Wu W, Liu Y, Nephew K, Han J, He C (2016) Abstract A51: DNA methylation in tumor, adjacent non-tumorous and normal breast tissues. Cancer Res 76(2 Supplement):A51CrossRefGoogle Scholar
  21. Xu J, Shetty PB, Feng W, Chenault C, Bast RC, Issa JPJ, Hilsenbeck SG, Yu Y (2012) Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome. BMC Cancer 12(1):1–7CrossRefGoogle Scholar
  22. Xue M, Lai SC, Xu ZP, Wang LJ (2015) Noninvasive DNA methylation biomarkers in colorectal cancer: a systematic review. J Dig Dis 16(12):699–712CrossRefPubMedGoogle Scholar
  23. Zhang J, Wang J, Xing H, Li Q, Zhao Q, Li J (2016) Down-regulation of FBP1 by ZEB1-mediated repression confers to growth and invasion in lung cancer cells. Mol Cell Biochem 411(1–2):331–340CrossRefPubMedGoogle Scholar
  24. Zheng J, Xiong D, Sun X, Wang J, Hao M, Ding T, Xiao G, Wang X, Mao Y, Fu Y, Shen K (2012) Signification of hypermethylated in cancer 1 (HIC1) as tumor suppressor gene in tumor progression. Cancer Microenviron 5(3):285–293CrossRefPubMedPubMedCentralGoogle Scholar
  25. Zhou ZQ, Cao WH, Xie JJ, Lin J, Shen ZY, Zhang QY, Shen JH, Xu LY, Li EM (2009) Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma. BMC Cancer 9(1):1–8CrossRefGoogle Scholar

Copyright information

© The Society for In Vitro Biology 2018

Authors and Affiliations

  1. 1.Faculty of PharmacyAl-Zaytoonah University of JordanAmmanJordan
  2. 2.Hamdi Mango Center for Scientific ResearchUniversity of JordanAmmanJordan

Personalised recommendations